I now have comprehensive content from multiple textbooks. Here is the full answer:
Hypoglycemia
Definition
Hypoglycemia is a plasma glucose concentration below normal fasting levels. While no single universally agreed cutoff exists, the most widely accepted thresholds are:
- <55 mg/dL (3.1 mmol/L) - symptoms typically begin; further workup indicated in non-diabetic patients
- <50 mg/dL (2.8 mmol/L) - impairment of cerebral function begins
- <40-50 mg/dL - severe symptomatic hypoglycemia in adults
- <20-30 mg/dL (<1.1-1.7 mmol/L) - severe CNS dysfunction
Note: The brain cannot store or synthesize glucose, and at rest the CNS consumes ~50% of all glucose used by the body - this makes the brain especially vulnerable.
Whipple's Triad - the classic diagnostic framework:
- Symptoms consistent with hypoglycemia
- Documented low plasma glucose level
- Relief of symptoms with correction of hypoglycemia
Pathophysiology
Hypoglycemia results from an imbalance where glucose utilization (by brain, erythrocytes, muscle, kidneys) exceeds glucose production (hepatic/renal gluconeogenesis + dietary intake).
Normal protective counterregulatory response:
- Cessation of insulin release
- Release of glucagon (increases hepatic glucose production within minutes)
- Epinephrine (stimulates glycogenolysis + gluconeogenesis, limits peripheral glucose use)
- Cortisol, growth hormone (slower response - hours)
In diabetic patients on insulin, this system fails because: (1) exogenous insulin cannot be "turned off," and (2) repeated hypoglycemic episodes blunt counterregulatory responses.
Symptoms
Symptoms fall into two categories:
1. Neurogenic (Autonomic) Symptoms - triggered by catecholamine/acetylcholine release:
| Catecholamine-mediated | Acetylcholine-mediated |
|---|
| Tremulousness | Diaphoresis (sweating) |
| Palpitations | Hunger |
| Anxiety, nervousness | Paresthesias |
| Tachycardia | |
2. Neuroglycopenic Symptoms - due to insufficient glucose supply to the CNS:
- Headache, dizziness, blurred vision
- Difficulty concentrating
- Confusion, behavioral changes
- Seizures
- Loss of consciousness, coma
- Death (if severe and prolonged)
Important: The rate of glucose decline matters. A rapid fall may trigger symptoms even before absolute hypoglycemic values are reached, while a gradual decline may produce fewer or no symptoms.
Causes
By Setting/Patient Type
In Diabetic Patients (most common overall cause):
- Excess insulin (most common): missed meals, reduced carbohydrate intake, excess dose, exercise
- Sulfonylureas and other insulin secretagogues
- Hypoglycemia unawareness (blunted counterregulatory response from prior episodes)
- Renal impairment (decreased drug clearance)
In Non-Diabetic Adults - Fasting Hypoglycemia:
| Category | Examples |
|---|
| Drugs | Insulin, sulfonylureas, ethanol, quinine, quinolones, pentamidine, beta-blockers, indomethacin |
| Critical illness | Hepatic failure (>80% dysfunction required), renal failure, sepsis, cardiac failure |
| Endogenous hyperinsulinism | Insulinoma, noninsulinoma pancreatogenous hypoglycemia, post-gastric-bypass hypoglycemia |
| Hormone deficiencies | Cortisol (Addison's disease), growth hormone, ACTH, glucagon, epinephrine, thyroid hormone |
| Non-pancreatic tumors | Large mesenchymal tumors; some secrete IGF-2 |
| Immune-mediated | Anti-insulin antibodies (associated with Graves' disease, multiple myeloma, SLE; more common in Japanese/Korean ancestry), anti-insulin receptor antibodies |
| Accidental/surreptitious | Factitious (exogenous insulin - low C-peptide, high insulin) |
| Enzyme defects | Glucose-6-phosphatase deficiency, others |
| Substrate deficiency | Starvation, malnutrition |
In Non-Diabetic Adults - Postprandial (Reactive) Hypoglycemia:
- Alimentary hyperinsulinism (post-gastrectomy, gastrojejunostomy, pyloroplasty, vagotomy) - most common cause
- Post-gastric bypass
- Anti-insulin or anti-insulin receptor antibodies
- Early type 2 diabetes (delayed but exaggerated insulin release)
In Neonates:
- Prematurity / small for gestational age
- Maternal diabetes or gestational diabetes mellitus
- Maternal eclampsia / toxemia
- Cold stress, polycythemia, respiratory distress syndrome
In Infants:
- Ketotic hypoglycemia
- Glycogen storage diseases
- Hereditary fructose intolerance, galactosemia
- Leucine hypersensitivity
- Reye syndrome
Special Situations
Hypoglycemia Unawareness: Loss of the warning (autonomic) symptoms before neuroglycopenia sets in. Caused by repeated prior hypoglycemic episodes that blunt counterregulatory responses. Risk factors: longer duration of diabetes, autonomic neuropathy, aggressive insulin therapy, decreased epinephrine secretion/sensitivity.
Somogyi Phenomenon: Excessive insulin dosing causes nocturnal hypoglycemia (often unrecognized during sleep) → counterregulatory rebound hyperglycemia in the morning → clinician incorrectly increases insulin dose → cycle worsens. Correct response: lower insulin dose or change timing.
Alcohol-Induced Hypoglycemia: Ethanol inhibits gluconeogenesis; worsened by low glycogen stores from malnutrition in chronic alcohol use disorder. Glucagon is ineffective because glycogen stores are depleted.
Insulinoma: Suspect when fasting plasma glucose <55 mg/dL with simultaneously elevated insulin (≥18 pmol/L), C-peptide (≥0.2 nmol/L), and proinsulin (≥5.0 pmol/L). Occurs in seemingly healthy individuals.
Diagnosis
| Test | Finding | Interpretation |
|---|
| Plasma glucose | <55 mg/dL during symptoms | Confirms hypoglycemia |
| Insulin | High | Endogenous (insulinoma) or exogenous |
| C-peptide | Low | Exogenous insulin administration |
| C-peptide | High | Insulinoma or sulfonylurea use |
| Proinsulin | High | Insulinoma |
| Sulfonylurea screen | Positive | Drug-induced |
| Anti-insulin antibodies | Present | Immune-mediated (autoimmune) hypoglycemia |
| Beta-hydroxybutyrate | Low during hypoglycemia | Suggests hyperinsulinism |
| Ethanol level | Elevated | Alcohol-induced |
The OGTT is not appropriate for evaluating suspected fasting hypoglycemia.
Management
Mild (alert patient):
- Oral glucose - sugary foods/beverages (the "15-15 rule" for diabetics: 15g carbohydrates, recheck in 15 min)
Moderate-Severe (IV access available):
- Adults: D50W (dextrose 50%), 1-3 ampules IV (raises glucose by 40-350 mg/dL)
- Children <8 years: D25W (2-4 mL/kg) or D10W - avoid D50W due to hyperosmolarity risk
- If alcohol use disorder is suspected: give thiamine first (before dextrose, to prevent Wernicke's encephalopathy)
No IV access:
- Glucagon 1-2 mg IM or SC - onset 10-20 min, peak at 30-60 min; repeat as needed
- Intranasal glucagon is available but less widely used
- Glucagon is ineffective in alcohol-induced hypoglycemia (depleted glycogen stores)
Sulfonylurea-induced hypoglycemia:
- Tends to be prolonged and severe
- Observe for at least 24 hours if hypoglycemia recurs after initial treatment
- High-risk: renal impairment, children, drug-naive patients
- Time to hypoglycemia can be delayed up to 18 hours after ingestion
All severe cases:
- Aspiration and seizure precautions
- Monitor closely - elderly patients may need several days for full CNS recovery
Sources
- Rosen's Emergency Medicine - Hypoglycemia chapter
- Tietz Textbook of Laboratory Medicine, 7th Ed. - Box 35.1 Causes of Hypoglycemia
- Henry's Clinical Diagnosis and Management by Laboratory Methods
- Brenner and Rector's The Kidney